GREENPOWER MOTOR CO INC (GP)

CA39540E3023 - Common Stock

0.835  +0.02 (+2.05%)

After market: 0.835 0 (0%)

Fundamental Rating

1

Taking everything into account, GP scores 1 out of 10 in our fundamental rating. GP was compared to 131 industry peers in the Machinery industry. GP may be in some trouble as it scores bad on both profitability and health. GP is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

GP had negative earnings in the past year.
In the past year GP has reported a negative cash flow from operations.
In the past 5 years GP always reported negative net income.
In the past 5 years GP always reported negative operating cash flow.

1.2 Ratios

GP's Return On Assets of -48.13% is on the low side compared to the rest of the industry. GP is outperformed by 89.76% of its industry peers.
GP's Return On Equity of -243.25% is on the low side compared to the rest of the industry. GP is outperformed by 92.13% of its industry peers.
Industry RankSector Rank
ROA -48.13%
ROE -243.25%
ROIC N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GP has a worse Gross Margin (11.30%) than 89.76% of its industry peers.
In the last couple of years the Gross Margin of GP has declined.
The Profit Margin and Operating Margin are not available for GP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%

0

2. Health

2.1 Basic Checks

GP does not have a ROIC to compare to the WACC, probably because it is not profitable.
GP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GP has been increased compared to 5 years ago.
The debt/assets ratio for GP is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.37, we must say that GP is in the distress zone and has some risk of bankruptcy.
GP's Altman-Z score of -2.37 is on the low side compared to the rest of the industry. GP is outperformed by 85.83% of its industry peers.
A Debt/Equity ratio of 1.63 is on the high side and indicates that GP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.63, GP is not doing good in the industry: 89.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF N/A
Altman-Z -2.37
ROIC/WACCN/A
WACC7.86%

2.3 Liquidity

A Current Ratio of 1.61 indicates that GP should not have too much problems paying its short term obligations.
The Current ratio of GP (1.61) is worse than 69.29% of its industry peers.
A Quick Ratio of 0.13 indicates that GP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.13, GP is doing worse than 97.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.13

6

3. Growth

3.1 Past

GP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.00%.
GP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -53.79%.
The Revenue has been growing by 45.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.91%
Revenue 1Y (TTM)-53.79%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-82.95%

3.2 Future

Based on estimates for the next years, GP will show a very strong growth in Earnings Per Share. The EPS will grow by 25.05% on average per year.
GP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.44% yearly.
EPS Next Y9.88%
EPS Next 2Y25.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-27.28%
Revenue Next 2Y23.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

GP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GP's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.05%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GP!.
Industry RankSector Rank
Dividend Yield N/A

GREENPOWER MOTOR CO INC

NASDAQ:GP (11/22/2024, 6:35:59 PM)

After market: 0.835 0 (0%)

0.835

+0.02 (+2.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.89M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.13%
ROE -243.25%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 11.3%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.61
Quick Ratio 0.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-47%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y9.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-53.79%
Revenue growth 3Y43.51%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y